Hepion Pharmaceuticals Inc (HEPA) Live Share Price, Invest From India

Hepion Pharmaceuticals Inc Stock Performance

as on June 6, 2026 at 5:01 am IST

$0.08
Day's Price Range
$0.08
$0.08
52 Week's Low
52 Week's High
$0.03
52-Week Price Range
$0.11
$0.08
57.38%
Downside
37.50%
Upside

Hepion Pharmaceuticals Inc share price movements today

Previous Close: $0.06
Open: $0.08
Volume: 1.2K
Day's Low - High: $0.08 - $0.08
52 Week Low - High: $0.03 - $0.11

Hepion Pharmaceuticals Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Hepion Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Hepion Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.05

Industry PE ratio

-3.616772151898734

PEG Ratio

EBITDA

-3.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-2058.63%

Hepion Pharmaceuticals Inc Stock Valuation

Track how Hepion Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Hepion Pharmaceuticals Inc in the last 5 years

Overview
Trends

Lowest (-6.66x)

September 30, 2021

Industry (-3.62x)

June 5, 2026

Today (0.05x)

June 5, 2026

Highest (-0.02x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.05x

Hepion Pharmaceuticals Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Hepion Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Hepion Pharmaceuticals Inc	BUY	$1.8M	NA	0.05	0.00%	NA

Analyst Recommendation on Hepion Pharmaceuticals Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Hepion Pharmaceuticals Inc. Average target price of $30

Hepion Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Hepion Pharmaceuticals Inc.

What analysts predicted

99.73%UPSIDE

Target Price

$30

Current Price

$0.08

Analyzed by

8 Analysts

Target

$30.00

Hepion Pharmaceuticals Inc target price $30, a slight upside of 99.73% compared to current price of $0.08. According to 8 analysts rating.

Hepion Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	0	-	-	-	0	-	-	-	-
Gross Profit	-	0	-	-	-	0	-	-	-	-
Operating Income	-7	-5	-8	-4	-1	-1	-1	0	0	0
EBITDA	-	-5	-8	-4	-	-6	-1	0	0	0
Interest Expense	-	0	0	0	-	0	0	0	0	0
Depreciation	0	0	-	-	-	-	-	-	-	-
Income Before Tax	-11	-5	-3	-4	-1	-6	-1	0	0	0
Income Tax Expense	-	-2	-	-	-	-	-	-	-	-
Net Income	-11	-2	-3	-4	-1	-6	-1	0	0	0
Net Profit Margin	0.00%	-2600.75%	0.00%	0.00%	0.00%	-9925.69%	0.00%	0.00%	0.00%	0.00%

Hepion Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	-
Operating Income	-20	-14	-7	-20	-30	-45	-48	-19	-4
EBITDA	-20	-14	-7	-20	-32	-44	-49	-14	-8
Interest Expense	3	0	0	0	0	0	0	1	0
Depreciation	0	0	0	0	0	0	0	0	-
Income Before Tax	-16	-9	-7	-20	-32	-45	-49	-16	-8
Income Tax Expense	-3	0	0	0	0	-2	0	-2	-
Net Income	-16	-9	-7	-20	-32	-42	-48	-13	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Hepion Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-2	-3	-4	-1	-6	-1	0	0	0
Operating Cash Flow	-3	-10	-2	-1	-1	-1	0	0	0
Investing Cash Flow	0	-	0	-	-	0	-	-	-
Financing Cash Flow	1	-	2	-	5	0	0	0	0
Change in Cash	-1	-10	0	-1	4	-1	0	0	0

Hepion Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-15	-9	-6	-20	-32	-42	-48	-13	-8
Operating Cash Flow	-8	-15	-7	-16	-31	-34	-40	-18	-3
Investing Cash Flow	0	0	0	0	0	0	-	0	0
Financing Cash Flow	1	12	18	43	81	-5	4	4	4
Change in Cash	-1	-3	11	26	50	-40	-36	-14	1

Global Institutional Holdings in Hepion Pharmaceuticals Inc

Funds	Holdings
XTX Topco Ltd	0%
Anson Funds Management LP	0.43%
BlackRock Inc	0.15%
Vanguard Group Inc	0.09%
Geode Capital Management, LLC	0.08%

See all

About Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States. It developed Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden; and titers of HBV, HCV, and HDV. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Morristown, New Jersey.

Organisation	Hepion Pharmaceuticals Inc
Headquarters	55 Madison Avenue, Morristown, NJ, United States, 07960
Industry	Biotechnology
CEO	Mr. Gary S. Stetz CPA
E-voting on shares	Click here to vote

Key Management of Hepion Pharmaceuticals Inc

Name	Title
Mr. Gary S. Stetz CPA	Interim CEO & Director
Sharen Pyatetskaya	Director of Investor Relations
Mr. Vincent LoPriore	Executive Chairman

FAQs

What is Hepion Pharmaceuticals Inc share price today?

Hepion Pharmaceuticals Inc share price today is $0.08 as on June 5, 2026 at 11:31 pm IST at the close of the market. Hepion Pharmaceuticals Inc share today touched a day high of $0.08 and a low of $0.08.

What is the 52 week high and 52 week low for Hepion Pharmaceuticals Inc share?

Hepion Pharmaceuticals Inc share touched a 52 week high of $0.11 on May 18, 2026 and a 52 week low of $0.03 on January 30, 2026. Hepion Pharmaceuticals Inc stock price today i.e. June 5, 2026 at 11:31 pm IST is closed at $0.08,which is 27.27% down from its 52 week high and 134.60% up from its 52 week low.

What is Hepion Pharmaceuticals Inc's market capitalisation today?

Hepion Pharmaceuticals Inc market capitalisation is $0.00T as on June 5, 2026 at 11:31 pm IST.

How to invest in Hepion Pharmaceuticals Inc Stock (HEPA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Hepion Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hepion Pharmaceuticals Inc Shares that will get you 18.7500 shares as per Hepion Pharmaceuticals Inc share price of $0.08 per share as on June 5, 2026 at 11:31 pm IST.

What is the minimum amount required to buy Hepion Pharmaceuticals Inc Stock (HEPA) from India?

Indian investors can start investing in Hepion Pharmaceuticals Inc (HEPA) shares with as little as ₹94.95 or $1 (as of June 8, 2026 at 6:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Hepion Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on June 8, 2026 at 6:41 am IST). Based on Hepion Pharmaceuticals Inc share’s latest price of $0.08 as on June 5, 2026 at 11:31 pm IST, you will get 125.0000 shares of Hepion Pharmaceuticals Inc. Learn more about fractional shares .